Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple intracellular proteins involved in apoptosis and reactive oxygen species (ROS) signaling refers to a complex network of molecular mediators that govern cell survival and death in response to oxidative stress. This group includes enzymes like superoxide dismutase, glutathione peroxidase, and caspases, as well as regulatory proteins such as the Bcl-2 family and the Nrf2 transcription factor (Redza-Dutordoir & Averill-Bates, 2016). These proteins work in concert to maintain redox homeostasis; when ROS levels exceed the cell's antioxidant capacity, these signaling pathways trigger apoptosis to eliminate damaged cells (NIH, 2023). Dysregulation of this balance is central to the pathogenesis of various conditions, including cancer, where cells evade apoptosis, and neurodegenerative disorders like amyotrophic lateral sclerosis (ALS), where oxidative stress drives neuronal loss (StatPearls, 2023). Pharmacological intervention typically involves the use of antioxidants or ROS scavengers that modulate these intracellular targets to either protect tissues from injury or sensitize resistant cells to death. For example, N-acetylcysteine acts by replenishing intracellular glutathione, thereby enhancing the cell's ability to neutralize ROS and prevent premature apoptosis (PubChem, 2024).
The mechanism of action involves the modulation of intracellular redox homeostasis by either directly scavenging reactive oxygen species (ROS) or serving as a precursor for endogenous antioxidants like glutathione. This shift in the redox environment inhibits the activation of pro-apoptotic signaling pathways, such as the JNK and p38 MAPK cascades, and prevents the mitochondrial release of cytochrome c, thereby halting the caspase-mediated apoptotic program (Sadowska et al., 2007; Redza-Dutordoir & Averill-Bates, 2016).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple intracellular proteins involved in apoptosis and reactive oxygen species signaling.